Saxenda vs Wegovy: Comparing Weight Loss Treatments

Last Updated On: May 21, 2025

In recent years, GLP-1 receptor agonist weight-loss injections have emerged as a breakthrough in the fight against obesity, with medications like Saxenda and Wegovy gaining significant attention. A 2025 study highlighted the potential of these treatments to aid in weight loss and reduce the risk of obesity-related cancers by nearly half. By analyzing data from thousands of adults, the research compared the effectiveness of these weight-loss injections against bariatric surgery, offering new insights into the possibilities of non-surgical weight management.

Saxenda, featuring liraglutide, and Wegovy, containing semaglutide, work by suppressing appetite and increasing feelings of fullness, helping individuals achieve sustainable weight loss. Patients take Saxenda daily, while they use Wegovy weekly; clinical trials show Wegovy delivers superior weight reduction results.

This article delves into a comparison between Saxenda and Wegovy, shedding light on their unique benefits, potential side effects, and suitability for various individuals.

Key Takeaways

• Saxenda and Wegovy are both GLP-1 receptor agonists that help with weight loss by suppressing appetite and increasing feelings of fullness, but they differ in dosage schedules and efficacy.
• Wegovy (semaglutide) has a longer half-life and requires weekly administration, whereas Saxenda (liraglutide) needs daily injections. This makes Wegovy more convenient for individuals seeking less frequent injections.
• Wegovy shows superior results, with an average weight loss of 15.8% compared to Saxenda’s 6.4%. Wegovy is especially effective for patients looking for more substantial, sustained weight loss.
• Both medications have similar side effects, including gastrointestinal symptoms such as nausea and diarrhea. However, Wegovy typically results in fewer discontinuations due to side effects than Saxenda.
• The choice between Saxenda and Wegovy depends on individual patient preferences, lifestyle, and treatment goals. Wegovy may be ideal for those seeking a more convenient weekly injection and greater weight loss results. Some patients and doctors may still prefer Saxenda for its established use and daily dosing.

About: Operating since 2016, Med Supply Solutions is known for being one of the industry’s top and trusted suppliers of cosmetic and viscosupplementation products. Contact our sales department for more information about buying Saxenda online.  

Comparing Mechanisms and Active Ingredients

Both Saxenda and Wegovy belong to the class of GLP-1 receptor agonists, which mimic the action of the natural hormone glucagon-like peptide-1 (GLP-1). By activating the GLP-1 receptors in the brain, these treatments effectively suppress appetite, enhance satiety, and ultimately reduce calorie intake, making them powerful tools in weight management.

• Saxenda (Liraglutide): Liraglutide has a relatively short half-life of about 13 hours, requiring once-daily subcutaneous injections to maintain consistent blood levels and therapeutic effect. Manufacturers initially developed Saxenda for type 2 diabetes under the brand Victoza and later approved it for weight loss at higher doses.
• Wegovy (Semaglutide): Semaglutide offers a longer half-life of approximately 7 days, allowing for a once-weekly dosing. Like liraglutide, it was initially developed for diabetes (Ozempic) but was later approved in a higher dose for chronic weight management under the name Wegovy. Its extended activity supports more stable GLP-1 receptor activation, potentially enhancing patient compliance and maintaining appetite suppression more effectively throughout the week.

Both medications act on the central nervous system to regulate hunger signals, delay gastric emptying, and promote satiety. However, semaglutide’s more prolonged duration of action allows for more continuous control of appetite. It may reduce the temptation to overeat between doses, particularly helpful for long-term adherence to weight loss plans.

Comparing Dosing and Administration Differences

The differences in the dosing schedules between Saxenda and Wegovy significantly impact patient convenience, preference, and adherence to the treatment regimen.

• Saxenda (Liraglutide): This medication is started at 0.6 mg once daily and increased by 0.6 mg weekly until the maintenance dose of 3.0 mg daily is reached. The titration process typically takes five weeks and helps reduce the risk of gastrointestinal side effects during the early phase of treatment.
• Wegovy (Semaglutide): Wegovy is initiated at 0.25 mg once per week, and the dose is gradually increased every four weeks to eventually reach the full maintenance dose of 2.4 mg weekly by week 17. The slow escalation helps the body adjust to the medication and minimizes common side effects such as nausea and bloating.

Many patients find the once-weekly dosing of Wegovy more convenient than Saxenda’s daily injections, especially those who struggle with medication adherence or prefer less frequent administration. This advantage may improve treatment continuity and better weight management outcomes over time.

For patients unfamiliar with injection techniques, learning how to inject Saxenda is a key consideration. A healthcare provider typically teaches patients the proper technique and provides guidance on safely storing and administering the medication.

Comparing Weight Loss Outcomes and Efficacy

Clinical trials have demonstrated significant differences in the effectiveness of Saxenda and Wegovy for weight loss, showcasing a greater weight reduction with Wegovy.

As shown in the table, Wegovy outperforms Saxenda in clinical trials, delivering more significant and long-lasting weight loss results. This makes Wegovy a more appealing option for patients seeking significant, sustained reductions in body weight.

Comparing Side Effects and Safety Profiles

Both Saxenda and Wegovy are generally well-tolerated but may cause gastrointestinal symptoms, particularly during the dose-escalation phase. These side effects usually subside as the body adjusts to the medication. While serious complications are rare, understanding the safety profile of both medications helps patients manage their expectations.

Though Wegovy has a slightly higher incidence of gastrointestinal symptoms, it typically results in fewer discontinuations due to side effects compared to Saxenda.

Rare side effects such as pancreatitis, gallbladder disease, and kidney issues have been associated with both treatments. Patients are encouraged to monitor for any unusual or severe symptoms and consult with their healthcare provider promptly.

Comparing Ideal Patient Profiles and Practical Use

Choosing between Saxenda and Wegovy depends on more than clinical efficacy, it also involves matching the medication to the patient’s lifestyle, medical history, treatment goals, and financial considerations. While both drugs are effective for weight management, they serve slightly different needs in practical settings. Understanding patient suitability helps ensure long-term adherence and optimal outcomes.

• Saxenda: This medication may be more appropriate for patients comfortable with daily injections and prefer a medication with a longer track record of clinical use. It may also be a viable option for individuals who cannot tolerate semaglutide or have contraindications to Wegovy, such as certain thyroid or gastrointestinal conditions.
• Wegovy: This treatment is best suited for patients seeking significant weight loss with the added convenience of once-weekly dosing. The simplified schedule is especially beneficial for those with busy routines or difficulties maintaining daily medication habits. Wegovy may also appeal to individuals who have not achieved desired results with previous weight loss therapies.

Beyond pharmacological differences, insurance coverage and out-of-pocket costs are crucial to accessibility. Saxenda and Wegovy are brand-name medications that may be subject to insurance restrictions or require prior authorization. Patients are encouraged to discuss these aspects with their healthcare provider and explore savings programs or assistance plans when available.

Conclusion

In comparing Saxenda vs Wegovy, both offer effective weight loss solutions when used alongside lifestyle changes. However, Wegovy’s superior efficacy and weekly dosing schedule make it a more convenient and effective option for many patients. Factors like patient preferences, side effect tolerability, and cost should also be considered when selecting the right treatment for an individual’s needs.

FAQs

1. Can I switch from Saxenda to Wegovy?

Yes, transitioning between these medications is possible. Consult your healthcare provider for a tailored plan to ensure safety and efficacy during the switch.

2.  Are these medications safe for long-term use?

Both drugs have been studied for long-term use and are generally considered safe. Regular monitoring by a healthcare professional is recommended to manage any potential side effects.

3.  Do I need to follow a specific diet on these medications?

While not mandatory, adhering to a calorie-restricted diet and regular exercise enhances the effectiveness of both Saxenda and Wegovy.

4. Are there any contraindications for these medications?

Individuals with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 should avoid these treatments. Before starting any new medication, always discuss your medical history with your healthcare provider.

References

Sagy YW, Ramot N, Battat E, et al. Glucagon-like peptide-1 receptor agonists compared with bariatric metabolic surgery and the risk of obesity-related cancer: an observational, retrospective cohort study. EClinicalMedicine. Published online May 1, 2025:103213. doi:10.1016/j.eclinm.2025.103213

Harris M, Harvie M, Renehan AG. Glucagon-like Peptide-1 (GLP-1) Receptor Agonists and Cancer Prevention: Methodological Pitfalls in Observational Studies. Cancers (Basel). 2025;17(9):1451. Published 2025 Apr 26. doi:10.3390/cancers17091451

Saxenda vs Wegovy: Which weight loss drug is right for you? Drugs.com. https://www.drugs.com/medical-answers/saxenda-wegovy-weight-loss-drug-right-you-3578889/

Marshall H. Saxenda vs. Wegovy. Published June 3, 2024. https://www.medicalnewstoday.com/articles/drugs-saxenda-vs-wegovy